Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Arkema S.A. (AKE.PA)
Colombes, FR
Arkema S.A. operates as a global producer and distributor of specialty chemicals and advanced materials. Its operations are strategically divided into four key business segments: Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates. Through its Adhesive Solutions segment, Arkema delivers bonding products essential for construction, building renovation, DIY projects, durable consumer goods, and various packaging and non-woven applications. This encompasses sealants, tiling and flooring adhesives, and waterproofing systems for both professional and individual users. Industrially, these solutions are vital for sectors like automotive, textiles, glazing, flexible and rigid packaging, and hygiene. The Advanced Materials division focuses on high-performance polymers like specialty polyamides and polyvinylidene fluoride, alongside a range of performance additives. These additives, including specialty surfactants, molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide, find critical applications across diverse industries. These span automotive and transportation, oil and gas, renewable energy, consumer products, electronics, construction, protective coatings, animal feed, and water treatment. Within Coating Solutions, Arkema supplies a comprehensive array of products, such as acrylics and coating resins for both European and North American markets. This segment also features Sartomer photocure resins and Coatex rheology additives, as well as decorative paints, industrial coatings, and adhesives. Its offerings cater to diverse industries, including paper manufacturing, superabsorbent materials, water treatment, oil and gas extraction, 3D printing, and electronics. Finally, the Intermediates segment delivers essential industrial chemicals, including fluorogases and acrylics. These are crucial for a variety of applications in construction, refrigeration and air conditioning, automotive manufacturing, coatings, and water treatment. Established in 2003, Arkema S.A. maintains its headquarters in Colombes, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46% | +0.54% | +5.36% | -0.69% | +23.15% | +24.45% | -7.55% | -25.42% | -39.91% | -8.76% | +108.48% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | -1 |
| Hold | 7 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | -1 |
-
Revenue growth Chemicals - Specialty: +4.7%-5.0% Q1'26: -8.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-81.5% Q1'26: -43.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.0% ★ Q1'26: -6.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.6% Q1'26: +3.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.7% Q1'26: +2.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.28× Q1'26: 14.98× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 6 EPS Ana. |
Dec 2027 15 Rev. Ana. 8 EPS Ana. |
Dec 2028 12 Rev. Ana. 4 EPS Ana. |
Dec 2029 11 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.91B
est: 5.95B (-0.7%)
|
5.90B
est: 6.37B (-7.4%)
|
6.40B
est: 6.51B (-1.7%)
|
6.10B
est: 6.19B (-1.5%)
|
5.95B
est: 6.05B (-1.6%)
|
7.68B
est: 7.75B (-0.8%)
|
7.54B
est: 7.44B (+1.3%)
|
8.33B
est: 8.35B (-0.2%)
|
8.82B
est: 8.65B (+1.9%)
|
8.74B
est: 8.90B (-1.8%)
|
7.88B
est: 7.76B (+1.6%)
|
9.52B
est: 9.31B (+2.3%)
|
11.55B
est: 11.59B (-0.3%)
|
9.51B
est: 9.43B (+0.9%)
|
9.54B
est: 9.54B (+0.1%)
|
9.07B
est: 9.02B (+0.6%)
|
9.18B
8.99B – 9.44B
+1.8% YoY
|
9.39B
8.95B – 9.80B
+2.3% YoY
|
9.66B
9.65B – 9.67B
+2.8% YoY
|
9.95B
9.61B – 10.31B
+3.0% YoY
|
| EBITDA |
762.00M
est: 282.74M (+169.5%)
|
1.32B
est: 802.54M (+64.2%)
|
1.03B
est: 700.23M (+47.5%)
|
904.00M
est: 706.35M (+28.0%)
|
781.00M
est: 600.98M (+30.0%)
|
1.11B
est: 757.21M (+46.5%)
|
1.16B
est: 866.61M (+34.2%)
|
1.29B
est: 1.20B (+7.9%)
|
1.36B
est: 1.23B (+10.7%)
|
1.32B
est: 1.27B (+4.2%)
|
1.19B
est: 1.09B (+9.0%)
|
2.27B
est: 1.16B (+96.4%)
|
1.82B
est: 1.21B (+50.2%)
|
1.33B
est: 1.53B (-13.2%)
|
1.31B
est: 1.44B (-9.1%)
|
1.25B
est: 1.46B (-14.4%)
|
1.49B
1.46B – 1.53B
+1.8% YoY
|
1.52B
1.45B – 1.59B
+2.3% YoY
|
1.57B
1.56B – 1.57B
+2.8% YoY
|
1.61B
1.56B – 1.67B
+3.0% YoY
|
| EBIT |
553.00M
est: -90.32M (+712.3%)
|
726.00M
est: 520.74M (+39.4%)
|
643.00M
est: 731.88M (-12.1%)
|
374.00M
est: 620.56M (-39.7%)
|
336.00M
est: 373.66M (-10.1%)
|
472.00M
est: 472.77M (-0.2%)
|
684.00M
est: 468.86M (+45.9%)
|
817.00M
est: 804.69M (+1.5%)
|
887.00M
est: 877.20M (+1.1%)
|
749.00M
est: 948.95M (-21.1%)
|
573.00M
est: 713.54M (-19.7%)
|
1.73B
est: 757.17M (+128.0%)
|
1.27B
est: 794.13M (+59.9%)
|
636.00M
est: 868.44M (-26.8%)
|
537.00M
est: 876.46M (-38.7%)
|
420.00M
est: 830.93M (-49.5%)
|
845.83M
827.92M – 869.69M
+1.8% YoY
|
865.65M
824.51M – 902.93M
+2.3% YoY
|
890.11M
889.05M – 891.16M
+2.8% YoY
|
916.87M
885.23M – 949.62M
+3.0% YoY
|
| Net Income |
347.00M
est: -225.15M (+254.1%)
|
-19.00M
est: 371.81M (-105.1%)
|
220.00M
est: -19.39M (+1,234.4%)
|
168.00M
est: 209.71M (-19.9%)
|
167.00M
est: 163.90M (+1.9%)
|
285.00M
est: 216.90M (+31.4%)
|
427.00M
est: 273.82M (+55.9%)
|
576.00M
est: 479.22M (+20.2%)
|
707.00M
est: 597.95M (+18.2%)
|
543.00M
est: 722.96M (-24.9%)
|
332.00M
est: 480.71M (-30.9%)
|
1.31B
est: 510.10M (+156.6%)
|
965.00M
est: 503.00M (+91.8%)
|
402.00M
est: 342.00M (+17.5%)
|
354.00M
est: 645.33M (-45.1%)
|
63.00M
est: 347.57M (-81.9%)
|
379.79M
331.85M – 427.74M
+9.3% YoY
|
470.97M
331.83M – 610.10M
+24.0% YoY
|
524.33M
416.61M – 632.05M
+11.3% YoY
|
604.63M
577.51M – 632.71M
+15.3% YoY
|
| SGA |
387.00M
est: 467.31M (-17.2%)
|
374.00M
est: 414.66M (-9.8%)
|
432.00M
est: 381.76M (+13.2%)
|
416.00M
est: 411.80M (+1.0%)
|
424.00M
est: 405.86M (+4.5%)
|
664.00M
est: 550.70M (+20.6%)
|
691.00M
est: 637.95M (+8.3%)
|
727.00M
est: 775.51M (-6.3%)
|
747.00M
est: 754.70M (-1.0%)
|
773.00M
est: 763.86M (+1.2%)
|
745.00M
est: 684.33M (+8.9%)
|
784.00M
est: 726.17M (+8.0%)
|
868.00M
est: 761.62M (+14.0%)
|
874.00M
est: 840.95M (+3.9%)
|
920.00M
est: 852.44M (+7.9%)
|
910.00M
est: 804.63M (+13.1%)
|
819.06M
801.72M – 842.16M
+1.8% YoY
|
838.25M
798.41M – 874.35M
+2.3% YoY
|
861.93M
860.91M – 862.95M
+2.8% YoY
|
887.85M
857.21M – 919.56M
+3.0% YoY
|
| EPS |
5.49
est: 5.15 (+6.7%)
|
-0.30
est: 8.44 (-103.6%)
|
3.42
est: 7.23 (-52.7%)
|
2.59
est: 5.74 (-54.9%)
|
2.53
est: 3.71 (-31.8%)
|
3.87
est: 4.25 (-9.0%)
|
5.24
est: 5.37 (-2.3%)
|
7.17
est: 7.20 (-0.4%)
|
9.27
est: 9.24 (+0.4%)
|
6.45
est: 8.04 (-19.8%)
|
3.98
est: 4.82 (-17.4%)
|
17.15
est: 10.87 (+57.8%)
|
12.81
est: 15.20 (-15.7%)
|
5.39
est: 4.58 (+17.7%)
|
4.51
est: 8.49 (-46.9%)
|
0.83
est: 4.57 (-81.8%)
|
4.96
4.37 – 5.63
+8.6% YoY
|
5.81
4.37 – 8.03
+17.1% YoY
|
6.86
5.48 – 8.32
+18.1% YoY
|
7.96
7.60 – 8.33
+16.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco STOXX Europe 600 Optimised Chemicals UCITS ETF SC00.DE | 2.21% | 6.40M | 0.20% |
| 2 | iShares STOXX Europe 600 Chemicals UCITS ETF (DE) EXV7.DE | 1.74% | 1.95M | 0.46% |
| 3 | iShares EURO STOXX Small UCITS ETF DJSC.L | 1.24% | 6.03M | 0.40% |
| 4 | iShares International Select Dividend ETF IDV | 0.78% | 62.94M | 0.50% |
| 5 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.58% | 4.31M | 0.33% |
| 6 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.58% | 6.13M | 0.58% |
| 7 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.56% | 3.99M | 0.40% |
| 8 | iShares STOXX Europe Small 200 UCITS ETF (DE) EXSE.DE | 0.54% | 3.66M | 0.20% |
| 9 | Sparkline International Intangible Value ETF DTAN | 0.49% | 71.6K | 0.55% |
| 10 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.44% | 3.43M | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thierry Le Henaff | Chairman & Chief Executive Officer | 3M | male |
| Beatrice Zilm | Vice President of Investor Relations | — | female |
| Christophe Villain | Executive Vice-President of Advanced Materials | — | male |
| Luc Benoit-Cattin | Executive Vice President of Industry & CSR | — | male |
| Marc Henri Florent Schuller | Chief Operating Officer of Coating Solutions, Intermediates & Advanced Materials | — | male |
| Marie-José Donsion | Chief Financial Officer | — | female |
| Richard Jenkins | Senior Vice President of Coating Solutions | — | male |
| Sophie Fouillat | Executive Vice-President of Strategy | — | female |
| Armand Ajdari | Chief Technology Officer | — | male |
| Thierry Parmentier | Executive Vice President of Human Resources & Corporate Communication | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AKE.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
